Why Are Dysplastic Naevi And Suspicious Pigmented Lesions Strictly Contraindicated For Cosmetic Laser Treatments? Protect Patients From Melanoma Misdiagnosis

Dysplastic naevi and suspicious pigmented lesions must not be treated cosmetically with laser or IPL because the energy can destroy or alter tissue that may need histological examination. It can also incompletely remove a lesion, obscure the clinical signs of melanoma, or create post-treatment changes that resemble melanoma—a phenomenon often termed pseudomelanoma. A qualified clinician must establish a clear diagnosis, with biopsy and histological assessment whenever malignancy cannot be confidently excluded.

The central risk is diagnostic, not merely cosmetic: laser or IPL treatment can eliminate the evidence needed to identify melanoma while leaving potentially abnormal cells behind. Suspicious or dysplastic lesions require dermatological assessment—not cosmetic destruction.

Why These Lesions Are Different

They may contain clinically important atypical cells

A dysplastic naevus is not automatically melanoma, but it may display atypical features associated with an increased risk of melanoma or with diagnostic uncertainty. A suspicious pigmented lesion may also represent an early melanoma or another tumour requiring medical treatment.

Cosmetic treatment should therefore never be used to remove diagnostic uncertainty.

Their appearance requires assessment over time

Colour, border, symmetry, structure, and change over time can provide important diagnostic information. Laser or IPL exposure may alter these features, making subsequent monitoring less reliable.

A lesion that becomes lighter or partially destroyed is not necessarily proven benign.

Why Histology Must Come First

Laser treatment can destroy the diagnostic specimen

Histology requires tissue architecture and cellular detail to be examined under a microscope. Thermal ablation, vaporisation, or optical destruction can remove or distort the very tissue needed to determine whether a lesion is benign, dysplastic, or malignant.

Once that tissue has been destroyed, a later biopsy may no longer provide a complete representation of the original lesion.

Incomplete destruction can leave abnormal cells behind

Many pigmented lesions extend into deeper skin layers. Superficial laser treatment may remove visible pigment while leaving deeper melanocytes or atypical cells intact.

This creates two problems: the lesion may not actually have been eliminated, and its remaining cells may be harder to evaluate clinically after treatment.

How Treatment Can Mask Melanoma

It can delay definitive medical intervention

If a suspicious lesion is treated cosmetically before diagnosis, apparent lightening or healing may create false reassurance. A melanoma could then remain untreated while its visible features are obscured.

That delay is the principal clinical concern—not simply an unsatisfactory cosmetic result.

It can create pseudomelanoma-like changes

Healing after laser treatment may produce irregular pigmentation, inflammation, scarring, or atypical cellular changes. These alterations can mimic melanoma histologically or clinically and are often described as pseudomelanoma.

Even when the original lesion was benign, treatment can make later assessment more difficult. If malignant cells were present, the altered appearance may further complicate recognition.

What Assessment Should Occur First?

A trained clinician should examine the lesion

Before any cosmetic laser or IPL procedure, pigmented lesions should be identified and assessed by an appropriately qualified healthcare professional. Dermoscopic examination may assist evaluation, but it does not replace biopsy when malignancy cannot be ruled out.

A lesion that is changing, irregular, asymmetrical, multicoloured, bleeding, itching, or otherwise uncertain should be referred rather than treated cosmetically.

Biopsy is the appropriate response to uncertainty

When the lesion’s nature is uncertain, the correct next step is diagnostic sampling and histological analysis. The aim is to establish a diagnosis before any treatment that could alter or destroy the lesion.

Cosmetic laser treatment should only be considered after a clear dermatological diagnosis confirms that the proposed treatment is appropriate.

Understanding the Trade-offs

Cosmetic convenience does not outweigh diagnostic safety

Laser treatment may appear attractive because it is quick and avoids a visible procedure. However, removing a lesion without first determining what it is sacrifices diagnostic information for a cosmetic benefit.

For a potentially malignant lesion, that is an unacceptable trade-off.

“Partial improvement” is not evidence of safe treatment

A lesion becoming flatter or lighter after treatment does not demonstrate that all abnormal cells have been removed. Deep residual cells may persist, and post-treatment pigmentation may make future changes difficult to interpret.

Clinical uncertainty should trigger referral, not experimentation

Energy-based devices cannot reliably convert a suspicious lesion into a safe cosmetic target. When benignity is uncertain, treatment should stop and medical evaluation should take priority.

How to Apply This Safely

The practical decision is straightforward: diagnose first, treat cosmetically only when appropriate.

If your primary focus is patient safety: Do not laser or IPL-treat a dysplastic or suspicious pigmented lesion; arrange qualified dermatological assessment and biopsy when indicated.
If your primary focus is cosmetic treatment planning: Exclude uncertain pigmented lesions from the treatment area until a documented diagnosis confirms that energy-based treatment is suitable.
If your primary focus is avoiding delayed melanoma diagnosis: Treat post-laser pigmentary change as a reason for reassessment, not as proof that the original lesion was benign.
If your primary focus is practitioner compliance: Record the pre-treatment skin assessment, referral or histology outcome, and the clinical rationale before proceeding.

When a pigmented lesion is uncertain, preserving diagnostic tissue and obtaining a definitive diagnosis is always more important than cosmetic removal.

Summary Table:

Contraindication Reason	Explanation
Destruction of diagnostic tissue	Laser or IPL can destroy tissue needed for histology, impeding accurate melanoma diagnosis.
Incomplete removal	Superficial treatment may leave deeper atypical cells, causing recurrence or masking malignancy.
Pseudomelanoma formation	Post-treatment changes can mimic melanoma, complicating future assessment.
Delayed diagnosis	Cosmetic treatment may provide false reassurance, delaying necessary medical intervention.

Ensure your clinic's laser protocols prioritize patient safety. BELIS provides advanced medical aesthetic devices designed for professional use, but we emphasize rigorous patient selection. Our laser systems—including Diode, Alexandrite, Nd:YAG, and Pico—are intended for trained clinicians who adhere to strict contraindications. For comprehensive training and safe aesthetic solutions, contact our experts today to discuss how BELIS can support your practice with high-quality equipment and safety guidelines. Contact us for a consultation.